On Tuesday shares of Citigroup Inc. (NYSE:C) closed at $53.74. Company’s sales growth for last 5 years was 5.20% and EPS growth for next 5 years is recorded as 25.50%. The Board of Directors of Citigroup Inc. (NYSE:C) declared a quarterly dividend on Citigroup’s common stock of $0.05 per share, payable on May 22, 2015 to stockholders.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) in last trading activity increased 7.51% to close at $72.27. Company weekly performance is 15.39% while its quarterly performance stands at 34.71%. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is 2.24% away from its 52 week high. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) had its price target increased by Canaccord Genuity from $68.00 to $78.00 in a research report sent to investors on Tuesday morning. The firm currently has a buy rating on the stock.
On last trading day Argan, Inc. (NYSE:AGX) moved down -0.55% to close at $32.63. Its volatility for the week is 2.92% while volatility for the month is 3.21%. AGX’s sales growth for past 5 years was 11.90% and its EPS growth for past 5 years was 27.90%. Argan, Inc. (NYSE:AGX) monthly performance is -3.18%. Argan Inc (NYSE:AGX) has entered into a share purchase agreement to acquire Atlantic Projects Company Limited (“APC”) in exchange for a combination of cash and common stock of Argan, Inc. APC is a leading provider of construction and technical services for power generation, oil & gas, industrial and process industry customers worldwide. The transaction is expected to close by May 31, 2015.
Clifton Bancorp Inc. (NASDAQ:CSBK) has 1.00% insider ownership while its institutional ownership stands at 62.00%. In last trading activity company’s stock closed at $14.05. On May 6, Clifton Bancorp Inc. (NASDAQ:CSBK) reported profit of $3.5 million in its fiscal fourth quarter. On a per-share basis, the Clifton, New Jersey-based company said it had net income of 13 cents. The bank posted revenue of $9.5 million in the period.
On last trading day Horizon Pharma plc (NASDAQ:HZNP) increased 1.24% to close at $28.61. Its volatility for the week is 5.26% while volatility for the month is 5.25%. HZNP’s EPS growth for past 5 years was -28.80%. Horizon Pharma plc (NASDAQ:HZNP) monthly performance is 0.42%. On May 8, Horizon Pharma plc (NASDAQ:HZNP), announced its first quarter 2015 financial results. Total net sales in the first quarter of 2015 were $113.1 million, compared with $51.9 million in the first quarter of 2014, representing 118 percent growth.